Theranica
PrivateLast Round
Series C
Aug 29, 2022
Total Funding Raised
$86M
Company Overview
Theranica is a digital therapeutics company that develops Nerivio, an FDA-cleared, prescribed wearable device for the acute and preventive treatment of migraine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theranica Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Theranica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 29, 2022 | ||||
| Series B | Mar 18, 2019 | ||||
| Series A | Jul 3, 2017 | ||||
| Seed | Sep 21, 2016 |
Key People
Founding team and executive leadership
Theranica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Corundum Open Innovation | Series C, Series A, Series B |
| New Rhein Healthcare Investors | Series C |
| aMoon | Series C, Series B |
| Omron Ventures | Series B |
| Takoa Invest | Series C, Series B |
| LionBird | Series C, Series A, Series B |
| Lightspeed Venture Partners | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Actively selling into Veterans Affairs, Department of Defense, and Indian Health Services.
- Oct 8, 2025
Attended CNS 2025 to share evidence on migraine interventions.
Theranica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Theranica's valuation, stock price, and market status.